Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III. [PDF]
Zhang Y, Fu L, Wang Y.
europepmc +1 more source
Prolactinoma in males: a single center experience in Northern Africa. [PDF]
El Yamani N +4 more
europepmc +1 more source
Ultra-rapid prolactin normalization with cabergoline in a premenopausal woman with epilepsy and giant prolactinoma. [PDF]
Ngougni Pokem P +4 more
europepmc +1 more source
Severe Iatrogenic Tricuspid Regurgitation. [PDF]
Amaral Pinto I, Macedo D, Rei Neto R.
europepmc +1 more source
A Diagnostic Challenge in the Emergency Department: Acute Intermittent Porphyria Unmasked After Cabergoline Exposure. [PDF]
Mina C, Ghanem H, Matar N.
europepmc +1 more source
A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma. [PDF]
Albasri E +7 more
europepmc +1 more source
Correlation between serum endocrine hormone levels and malignancy degree of prolactinoma and their predictive value for patient prognosis. [PDF]
Yu P, Ren Y, Feng B, Yu Y, Mei P, Zhu Y.
europepmc +1 more source
Severe hyperprolactinemia secondary to primary hypothyroidism with normal pituitary imaging. [PDF]
Meena A.
europepmc +1 more source
The clinical value of [<sup>18</sup>F]-fluoro-ethyl-L-tyrosine PET ([<sup>18</sup>F]FET-PET) correlated with MRI in patients with functioning pituitary adenomas: an observational cohort study. [PDF]
van der Hoeven LS +9 more
europepmc +1 more source
Widespread invasion of a giant prolactinoma via valveless venous channels: illustrative case. [PDF]
Liang AS +4 more
europepmc +1 more source

